Back to Search Start Over

Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression.

Authors :
He, Ruimin
Liu, Yifan
Fu, Weijie
He, Xuan
Liu, Shuang
Xiao, Desheng
Tao, Yongguang
Source :
Molecular Cancer. 11/29/2024, Vol. 23 Issue 1, p1-54. 54p.
Publication Year :
2024

Abstract

Cell death is a fundamental part of life for metazoans. To maintain the balance between cell proliferation and metabolism of human bodies, a certain number of cells need to be removed regularly. Hence, the mechanisms of cell death have been preserved during the evolution of multicellular organisms. Tumorigenesis is closely related with exceptional inhibition of cell death. Mutations or defects in cell death-related genes block the elimination of abnormal cells and enhance the resistance of malignant cells to chemotherapy. Therefore, the investigation of cell death mechanisms enables the development of drugs that directly induce tumor cell death. In the guidelines updated by the Cell Death Nomenclature Committee (NCCD) in 2018, cell death was classified into 12 types according to morphological, biochemical and functional classification, including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, PARP-1 parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence and mitotic catastrophe. The mechanistic relationships between epigenetic controls and cell death in cancer progression were previously unclear. In this review, we will summarize the mechanisms of cell death pathways and corresponding epigenetic regulations. Also, we will explore the extensive interactions between these pathways and discuss the mechanisms of cell death in epigenetics which bring benefits to tumor therapy. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14764598
Volume :
23
Issue :
1
Database :
Academic Search Index
Journal :
Molecular Cancer
Publication Type :
Academic Journal
Accession number :
181252883
Full Text :
https://doi.org/10.1186/s12943-024-02172-y